We take a look back at the week in pharmacy

There’s growing concern that when codeine-containing analgesics are upscheduled early next year, consumers may turn to ibuprofen to manage pain… which may be a problem given the increasing amount of evidence to support the NSAID link to heart attack. NSAIDs are currently being sold like lollies, said pharmacist Catherine Bronger this week.

One of the biggest stories this week was the Wannacry malware crisis, which mostly left Australia unscathed, though pharmacies may still be vulnerable, and so the Guild issued some helpful advice to proprietors. In the UK, pharmacists stepped up to help out when the crisis caused chaos across the health system.

A NSW pharmacist spoke out about the important issue of diversity in pharmacy leadership: it’s not just about women, says Veronica Nou. And Greens leader Richard di Natale has praised Medicines Australia‘s changes to its code of conduct.

The National Institute of Complementary Medicines is drawing heat again for promoting unproven products. FIP is tackling the ever-worsening international problem of medicines shortages. And the TGA issued a reminder about the transition to new medicine labels and listings for allergens.

Meanwhile, in the US state of Illinois, moves are underway to cap the hours and limit the amount of prescriptions a pharmacist can fill, as well as mandating some counselling, in a bid to reduce dispensing errors. We know workloads and dispensing errors are an issue here, too, thanks to PDL data, so we’d like to know what you think: tell us in our poll, here.